Patients to be diagnosed faster thanks to findings from largest monkeypox international study | Our news

  1. Contrast:

Patients to be diagnosed faster thanks to findings from largest monkeypox international study

  • An international group of clinicians and researchers have identified new clinical symptoms in people infected with monkeypox
  • Their findings will help to diagnose patients faster, slow the spread of infection and help researchers to prioritise the limited global supply of monkeypox vaccines and treatments for the most at risk communities

  • The virus currently disproportionately affects gay and bisexual men, with 98% of infected persons being from this group.

An international group of clinicians and researchers have identified new clinical symptoms in people infected with monkeypox. Their findings will help to diagnose patients faster, slow the spread of infection and help researchers to prioritise the limited global supply of monkeypox vaccines and treatments for the most at risk communities.

In a study of 528 confirmed monkeypox infections across 16 different countries, researchers identified symptoms including single genital lesions and sores on the mouth or anus. These are not in current medical definitions of monkeypox and are similar to those of sexually transmitted infections (STIs), which can easily lead to misdiagnosis.

In some people, anal and oral symptoms have led to people being admitted to hospital for management of pain and difficulties swallowing. This is why it’s so important that these new clinical symptoms are recognised, and healthcare professionals know how to identify and manage the disease. Misdiagnosis can make it harder to control the spread of the virus.

The virus currently disproportionately affects gay and bisexual men, with 98% of infected persons being from this group. Although sexual closeness is the most likely route of transmission in most of these cases, researchers stress that the virus can be transmitted by any close physical contact through large respiratory droplets and potentially through clothing and other surfaces.

There is a global shortage of both vaccines and treatments for human monkeypox infection. The findings of this study, including identifying people who are most at risk of infection, will help to aid the global response to the virus.

Dr John Thornhill, Consultant Physician in Sexual Health and HIV and Clinical Senior Lecturer at Barts NHS Health Trust and Queen Mary University of London, said: “It is important to stress that monkeypox is not a sexually transmitted infection in the traditional sense; it can be acquired through any kind of close physical contact. However, our work suggests that most transmissions so far have been related to sexual activity - mainly, but not exclusively, amongst men who have sex with men. This research study increases our understanding of the ways it is spread and the groups in which it is spreading, which will aid rapid identification of new cases and allow us to offer prevention strategies, such as vaccines, to those individuals at higher risk

“In addition, we identified new clinical presentations in people with monkeypox. While we expected various skin problems and rashes, we also found that one in ten people had only a single skin lesion in the genital area and 15 percent had anal and/or rectal pain. These different presentations highlight that monkeypox infections could be missed or easily confused with common sexually transmitted infections such as syphilis or herpes. We therefore suggest broadening the current case definitions.

“We have also found monkeypox virus in a large proportion of the semen samples tested from people with monkeypox. However, this may be incidental as we do not know that it is present at a high enough level to facilitate sexual transmission. More work is needed to understand this better.”

Dr Vanessa Apea, Consultant Physician in Sexual Health and HIV at Barts Health NHS Trust said: “The mammoth response to monkeypox in the UK has been a great example of the power of collaborative multi-disciplinary working across sexual health, HIV, infectious diseases, health protection teams, third sector agencies and so many others. There has been a steep learning curve and sharing experiences and outcomes is critical to ensuring we can provide the best care for all persons affected by monkeypox.”

Chloe Orkin, Professor of HIV Medicine at Queen Mary University of London and Director of the SHARE collaborative, said: “Viruses know no borders and monkeypox infections have now been described in 70 countries and in more than 13,000 people. This truly global case series has enabled doctors from 16 countries to share their extensive clinical experience and many clinical photographs to help other doctors in places with fewer cases.

“We have shown that the current international case definitions need to be expanded to add symptoms that are not currently included, such as sores in the mouth, on the anal mucosa and single ulcers. These particular symptoms can be severe and have led to hospital admissions so it is important to make a diagnosis. Expanding the case definition will help doctors more easily recognise the infection and so prevent people from passing it on. Given the global constraints on vaccine and anti-viral supply for this chronically underfunded, neglected tropical infection, prevention remains a key tool in limiting the global spread of human monkeypox infection.”

About the study:

A case series which is the result of an international collaboration across 16 countries was published on 21 July 2022 in New England Journal of Medicine (NEJM). The study, which was carried out in response to the emerging global health threat, identifies new clinical symptoms of monkeypox infection, which will aid future diagnosis and help to slow the spread of infection. This largest case series to date, it reports on 528 confirmed infections at 43 sites between 27 April and 24 June 2022.

“Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022.” Thornhill JP, Rockstroh J, Palich R, Habibi MS, Boesecke CB, Yakubovsky M, Blanco JL, Maltez FM, Pourcher V, Pintado C, Hansen AE, Lezama JI, Makofane K, Nozza S and Orkin CM. New England Journal of Medicine. DOI: 10.1056/NEJMoa2207323.

Read more: 

Comments

Add a response »
*

No comments yet: why not be the first to contribute?